Company ProMIS Neurosciences, Inc. Toronto S.E.
Equities
PMN
CA74346M4065
Biotechnology & Medical Research
Business Summary
Number of employees: 7
Managers
Managers | Title | Age | Since |
---|---|---|---|
Neil Warma
CEO | Chief Executive Officer | 61 | 12/05/21 |
Neil Cashman
FOU | Founder | 72 | 22/01/04 |
Eugene Williams
CHM | Chairman | 64 | 28/06/15 |
Daniel Geffken
DFI | Director of Finance/CFO | 67 | 21/03/17 |
Gavin Malenfant
COO | Chief Operating Officer | 61 | 21/10/21 |
Larry Altstiel
CTO | Chief Tech/Sci/R&D Officer | 74 | 18/04/22 |
Dennis Chen
PRN | Corporate Officer/Principal | - | - |
David Wishart
PRN | Corporate Officer/Principal | - | 26/05/21 |
Ernest D. Bush
PRN | Corporate Officer/Principal | - | 02/04/18 |
Johanne Kaplan
PRN | Corporate Officer/Principal | 64 | 20/07/16 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
William W. Wyman
BRD | Director/Board Member | 86 | 07/03/14 |
Neil Cashman
FOU | Founder | 72 | 22/01/04 |
Neil Warma
CEO | Chief Executive Officer | 61 | 12/05/21 |
Eugene Williams
CHM | Chairman | 64 | 28/06/15 |
Patrick Kirwin
BRD | Director/Board Member | - | 28/06/15 |
Director/Board Member | 41 | 31/08/21 | |
Director/Board Member | 65 | 21/09/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 18,961,116 | 14,344,157 ( 75.65 %) | 0 | 75.65 % |
Company contact information
ProMIS Neurosciences, Inc.
1920 Yonge Street Suite 200
M4S 3E2, Toronto
+416 847 6898
http://www.promisneurosciences.comSector
1st Jan change | Capi. | |
---|---|---|
-1.17% | 104B | |
+2.87% | 97.47B | |
+3.61% | 22.25B | |
-14.77% | 21.68B | |
-8.79% | 18.2B | |
-39.98% | 17.02B | |
-13.21% | 16.36B | |
+8.55% | 14.39B | |
+35.75% | 12.37B |